Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Capricor Therapeutics and Janssen Biotech, Inc. Enter Into Collaboration Agreement and Exclusive License Option

Globe Newswire January 6, 2014

Enanta Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Business Wire January 6, 2014

Significant Clinical Findings on ALS Patient Treated with BrainStorm's NurOwn Featured in "Muscle and Nerve"

Business Wire January 6, 2014

ChromaDex® Announces $62 Million Ingredient Agreement with Network Marketing Company 5LINX®

PR Newswire January 6, 2014

StemCells, Inc. Posts Letter to Shareholders

Globe Newswire January 6, 2014

Cytomedix Announces Completion of RECOVER-Stroke Trial Enrollment and Update on Bright Cell Technology

Marketwired January 6, 2014

IOCOM's Visimeet to Be Used in University of Birmingham's EMBO Conference by Attendees Around the World

Marketwired January 6, 2014

Cellceutix Submits Application to Institutional Review Board to Commence Clinical Trials of Anti-Psoriasis Drug Prurisol

Marketwired January 6, 2014

Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations

Business Wire January 6, 2014

Clovis Oncology to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Business Wire January 6, 2014

Galleon Scientists Win Prestigious Research Awards for First-in-Class Treatment of Emerging Perioperative Sleep Apnea Epidemic

Business Wire January 6, 2014

Luoxis Establishes Study Collaborations with Two Research Centers in Oxidative Stress

PR Newswire January 6, 2014

Amarantus to Present at Biotech and Healthcare Conferences During JP Morgan Week in San Francisco

Globe Newswire January 6, 2014

Qualcomm Smart Gateway Platform Transforms Connected Experiences in the Home to Enable a New Breed of Applications and Services

PR Newswire January 6, 2014

Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors

Business Wire January 6, 2014

GE To Expand in Life Sciences with Acquisition of Strategic Assets from Thermo Fisher Scientific

Business Wire January 6, 2014

Cyclacel Pharmaceuticals to Present at Biotech Showcase(TM) 2014 Conference

Globe Newswire January 6, 2014

Cancer Genetics Appoints John Pappajohn Chairman of the Board of Directors

Globe Newswire January 6, 2014

NewLink Genetics to Present at the 32nd Annual JP Morgan Healthcare Conference

Marketwired January 6, 2014

ANGLO AFRICAN AGRICULTURE PLC - Exercise of warrants & issued share capital

PR Newswire January 6, 2014